SSKN STRATA Skin Sciences, Inc.: institutional ownership and insider trading
1 funds reported holding $20.6K of STRATA Skin Sciences, Inc. in their latest 13F filings; in Q1 2026 funds net bought $0, with 0 new positions and 13 funds selling out; over the last 12 months insiders bought $7.03K and sold $18.8K on the open market; over its last four quarters it reported revenue of $30.7M and net income of −$6.26M.
SSKN revenue and earnings
- Quarter ended Dec 31, 2025: revenue $9.29M, net income $58.0K, EPS 0.14
- Quarter ended Sep 30, 2025: revenue $6.93M, net income −$1.62M, EPS -0.36
- Quarter ended Jun 30, 2025: revenue $7.66M, net income −$2.58M, EPS -0.62
- Quarter ended Mar 31, 2025: revenue $6.81M, net income −$2.12M, EPS -0.51
Largest institutional holders of SSKN
- VANGUARD GROUP INC — $20.6K
Recent SSKN insider trades
- Nov 18, 2025: Rubinstein Samuel bought 5,000 shares ($7.03K)
- Nov 17, 2025: Rubinstein Samuel sold 14,094 shares ($18.8K)
5%+ owners
- Accelmed Partners, L.P.: 27.4% (Schedule 13D/A, filed Sep 5, 2025)
- Lincoln Alternative Strategies LLC: 6.9% (Schedule 13G, filed Sep 4, 2025)